Evidence map›Paper›PMID 42609620›Full record

ArticleBrain communications2026

Incomplete T-cell tolerance and epitope-specific responses to the NR1 subunit in NMDA receptor antibody-associated encephalitis.

Rachel L Brown, Adriana Albuquerque, Sharyn Thomas, Angelika Holler, Heather Angus-Leppan, Alessandro Sette, Cecilia Lindestam Arlehamn, Melanie Hart, Michael S Zandi, Angela Vincent and 3 more

Abstract read
In one paragraph

Article in Brain communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Rachel L BrownUCL Institute of Immunity and Transplantation, University College London, London NW3 2PP, UK.ORCID https://orcid.org/0000-0002-9932-0228
Adriana AlbuquerqueUCL Institute of Immunity and Transplantation, University College London, London NW3 2PP, UK.ORCID https://orcid.org/0000-0003-3391-0396
Sharyn ThomasUCL Institute of Immunity and Transplantation, University College London, London NW3 2PP, UK.
Angelika HollerUCL Institute of Immunity and Transplantation, University College London, London NW3 2PP, UK.
Heather Angus-LeppanDepartment of Clinical Neurosciences, Royal Free Hospitals NHS Foundation Trust, London NW3 2QG, UK.
Alessandro SetteCenter for Infectious Disease, Division of Vaccine Discovery, La Jolla Institute for Immunology, San Diego, CA 92037, USA.
Cecilia Lindestam ArlehamnCenter for Infectious Disease, Division of Vaccine Discovery, La Jolla Institute for Immunology, San Diego, CA 92037, USA.
Melanie HartDepartment of Neuroinflammation, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.
Michael S ZandiNational Hospital for Neurology and Neurosurgery, University College London Hospitals Foundation NHS Trust, London WC1N 3BG, UK.ORCID https://orcid.org/0000-0002-9612-9401
Angela VincentNuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UK.ORCID https://orcid.org/0000-0003-2395-8695
Hans J StaussUCL Institute of Immunity and Transplantation, University College London, London NW3 2PP, UK.
Michael P LunnDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.ORCID https://orcid.org/0000-0003-3174-6027
Emma C MorrisUCL Institute of Immunity and Transplantation, University College London, London NW3 2PP, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

NMDA receptor antibody-associated (NMDAR-Ab) encephalitis primarily affects young women and children and often requires prolonged intensive care admission. Currently available first- and second-line therapies are effective, but patients can be refractory and residual deficits are not uncommon. Although B-cell lineages and specific NMDAR (NR1 subunit) antibodies have been examined in detail, the subtypes and roles of antigen-specific T cells in providing T-cell help to drive the IgG antibody response, cytotoxic effects or other roles have not been reported. Peripheral blood mononuclear cells from eight patients and eight healthy volunteers underwent three rounds of stimulation with pooled 15-mer peptides spanning the length of the NR1 sequence. At each round of stimulation, functional CD4+ and CD8+ T-cell responses to NR1-derived peptide pools were assessed using flow cytometry. CD4+ and CD8+ T responses to NR1-derived peptide pools were identified in both patients and healthy volunteers. Patient CD4+ T-cell responses were more frequent compared to healthy volunteers after the first round of stimulation, with fewer responses after the third round. Healthy volunteer CD4+ T cells showed the opposite trend (

Indexed as

immune toleranceNMDA receptorT cells

Identifiers

PMID42609620
PMCPMC13479385

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.